Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

Delayed Quote. Delayed  - 05/05 04:24:38 pm
20290 ILa   +0.05%
09:17a Cell Source Improving Immunotherapy with T-Cell Twist
05/04TEVA PHARMACEUT : quaterly earnings release
05/04 TEVA PHARMACEUT : FDA Expands Approval of Teva’s Breath-actuat..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on TEVA PHARMACEUTICAL INDUST
09:17a Cell Source Improving Immunotherapy with T-Cell Twist
05/05 TEVA PHARMACEUTICAL : Jennifer Morrison Reveals How Her Journey with Migraine is..
05/04TEVA PHARMACEUTICAL INDUSTRIES LIMIT : quaterly earnings release
05/04 TEVA PHARMACEUTICAL : FDA Expands Approval of Teva’s Breath-actuated Inhal..
05/03 TEVA PHARMACEUTICAL : Histadrut calls work dispute at Teva's Kfar Saba plant
05/02DJActivist Investor to Pressure Stada AG to Explore Potential Sale Activist Inv..
04/29 TEVA PHARMACEUTICAL : Announces FDA Approval of ProAir RespiClick® (albuterol su..
04/28 TEVA PHARMACEUTICAL : to Report First Quarter 2016 Financial Results on May 9, 2..
04/28 TEVA PHARMACEUTICAL : Presents New Data for SD-809 in Huntington Disease at 68th..
04/25 TEVA PHARMACEUTICAL : Jennifer Morrison Reveals How Her Journey with Migraine is..
04/23 TEVA PHARMACEUTICAL : TEVA) Stake Cut by Westfield Capital Management Co. LP
04/21 TEVA PHARMACEUTICAL : to Present Data Highlighting Company's Pipeline in Neurolo..
04/19 TEVA PHARMACEUTICAL : Presents New Data for SD-809 in Huntington Disease at 68th..
04/18 TEVA PHARMACEUTICAL : to Report First Quarter 2016 Financial Results on May 9, 2..
04/18 TEVA PHARMACEUTICAL : Presents New Data for SD-809 in Huntington Disease at 68th..
04/12 TEVA PHARMACEUTICAL : Copaxone exclusivity threatened in Europe
04/12 TEVA PHARMACEUTICAL : to Present Data Highlighting Companys Pipeline in Neurolog..
04/12 TEVA PHARMACEUTICAL : to Present Data Highlighting Company’s Pipeline in N..
04/07DJAllergan Completes Licensing Deal After Pfizer Bid Collapses
04/06 Antares Pharma Discloses Pen 1 Development Project as Teriparatide
04/06 Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change
04/06 Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change
04/06 Obama's inversion curbs kill Pfizer's $160 billion Allergan deal
04/04 TAKEDA PHARMACEUTICAL : Teva set up new business venture Teva Yakuhin Ltd in Jap..
04/04 TEVA PHARMACEUTICAL : Muhlenkamp & Co. Inc. Maintains Stake in Teva Pharmaceutic..
04/04 Factbox - Price hikes shore up revenue for top-selling U.S. drugs
04/04 Exclusive - Makers took big price increases on widely used U.S. drugs
04/02 HSBC : Teva Pharmaceutical Industries (TEVA) Hold Rating Reaffirmed at HSBC
04/01 TEVA PHARMACEUTICAL : Takeda and Teva Establish “Teva Takeda Yakuhin Ltd.&..
03/31 TEVA PHARMACEUTICAL : Announces FDA Approval of CINQAIR® reslizumab Injection
03/31 TEVA PHARMACEUTICAL : Announces Launch of Generic Campral® in the United States
03/30 TEVA PHARMACEUTICAL : TEVA) Given Outperform Rating at Leerink Swann
03/30DJFTC Seeks More Information on Pfizer-Allergan Merger
03/30DJNew FDA Guidelines Ease Access to Abortion Procedure
03/24 TEVA PHARMACEUTICAL : Patent Issued for N-Ethyl-N-Phenyl-1,2-Dihydro-4,5-Di-Hydr..
03/23 TEVA PHARMACEUTICAL : Announces FDA Approval of CINQAIR® (reslizumab) Injection
03/22 TEVA PHARMACEUTICAL : Announces Launch of Generic Campral® in the United States
03/21 TIMELINE : Shakeup at Valeant as longtime CEO Pearson leaving
03/17 TEVA PHARMACEUTICAL : Completes Generic Pulmicort® Respules Portfolio with the L..
03/15 TEVA PHARMACEUTICAL : seeks salary hike for CEO
03/15 TEVA PHARMACEUTICAL : BRIEF: Teva-Allergan deal completion delayed
03/15 TIMELINE : More trouble for Valeant as possible debt default looms
03/15DJTeva Acquisition of Allergan Generics Unit Delayed--Update
03/15DJTeva Acquisition of Allergan Generics Unit Delayed
03/15DJTeva Acquisition of Allergan Generics Unit Delayed
03/15 Teva Pharm sees close of $40.5 billion Allergan generics deal by June
03/11 TEVA PHARMACEUTICAL : to Present at the Barclays Global Healthcare Conference
03/10 ALLERGAN : BRIEF: EU approves Teva acquisition of Allergan's generics business
03/10DJEU Approves Teva Takeover of Allergan Generics Unit -- Update
03/10DJEU Approves Teva Takeover of Allergan Generics Unit
03/10DJEU Approves Teva's Takeover of Allergan's Generics Unit
03/10 TEVA PHARMACEUTICAL : Receives European Commission Approval for the Allergan Gen..
03/10 EU approves Teva bid for Allergan's generics with conditions
03/10 EXCLUSIVE - TEVA SET TO WIN EU OKAY : sources
03/09DJTeva Deal for Allergan Generics Unit Expected to Get Europe OK -Reuters
03/09 TEVA PHARMACEUTICALS : Initiates Voluntary Nationwide Recall of One Lot of Amika..
03/09 TEVA PHARMACEUTICAL : Completes Generic Pulmicort® Respules Portfolio with the L..
03/03 ELECTRA : and Tidhar to build new Teva HQ
03/03 TEVA PHARMACEUTICALS : Embarks on Strategic Corporate Identity Program to Build ..
03/03 TEVA PHARMACEUTICAL : Completes Acquisition of Rimsa
03/03 TEVA PHARMACEUTICAL : to Present New Respiratory Data at the 2016 Academy of All..
03/02 TEVA PHARMACEUTICAL : to Present at the Cowen & Company 36th Annual Healthcare C..
03/01 TEVA PHARMACEUTICAL : Mylan boosted as Teva's generic EpiPen further delayed
02/29 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : ex-dividend day for interim dividend
02/25 TEVA PHARMACEUTICAL : Canada Announces the Launch of (Pr)-Tobramycin Inhalation ..
02/24 TEVA PHARMACEUTICAL : to build new global brand
02/24 TEVA PHARMACEUTICALS : Embarks on Strategic Corporate Identity Program to Build ..
02/22DJAllergan Tops Expectations on Botox Sales
02/19 Teva offers EU concessions over Allergan generics deal
02/18 ALLERGAN : BRIEF: Teva offering concessions for Allergan takeover - report
02/15 ALLERGAN : Teva's Desheh: We met expectations or better
02/14 TEVA PHARMACEUTICAL : BRIEF: Teva CEO Vigodman's 2015 salary cost: $5.7m
02/12DJLILLY : U.K. Court Rules in Opponent's Favor on Alimta Patent
02/12 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Healthcare Trade Setups to Win -- Teva Ph..
02/11 TEVA PHARMACEUTICAL : Files 2015 Annual Report on Form 20-F
1  2  3  4  5  6  7  8  9  10Next
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials